Detection of Opioid Overdoses and Poisonings in Electronic Medical Records as Compared to Medical Chart Reviews

Size: px
Start display at page:

Download "Detection of Opioid Overdoses and Poisonings in Electronic Medical Records as Compared to Medical Chart Reviews"

Transcription

1 Detection of Opioid Overdoses and Poisonings in Electronic Medical Records as Compared to Medical Chart Reviews Dennis McCarty, Shannon Janoff, Paul Coplan, Nancy Perrin, Cynthia Campbell, Elizabeth Shuster, G Thomas Ray, Howard Chilcoat, Carla Green 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

2 Disclosures A Research Service Agreement between the Kaiser Permanente Center for Health Research & Purdue Pharma LP supported data extraction and analysis. Dr. McCarty is the PI on Research Service Agreements with Purdue Pharma LP and Alkermes and awards from NIH (U10 DA015815, P50 DA018165, R01 DA029716, R33 DA035640) 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 2

3 Affiliations Kaiser Permanente Center for Health Research Carla A. Green, Shannon L. Janoff, Nancy A. Perrin, Elizabeth Shuster Kaiser Permanente Division of Research Cynthia Campbell, G. Thomas Ray Purdue Pharma, LP Howard Chilcoat, Paul Coplan Oregon Health & Science University Dennis McCarty 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 3

4 SOURCE: Study of OxyContin Use, Risk & Critical Events Mixed methods study assessing change in opioid overdose and poisoning events following introduction of abuse-deterrent formulation of OxyContin Data from two integrated health plans Validation sub-study Identified opioid overdose and poisoning events using coded medical terminology verified against chart review 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 4

5 Design and Methods: Setting and Coded Medical Terminology Setting Kaiser Permanente Northwest and Kaiser Permanente Northern California Extracted OOP events between August October 2012 from EMR Used two sets of coded medical terminology ICD opioid poisoning codes ICD poisoning codes: , , , , E850.0, E850.1, E850.2, ICD poisoning COD codes: 9650, T40.0, T40.1, T40.2, T40.3, T40.4, X42, X62 and Y12 ICD and HCPCS opioid adverse effect codes plus codes for OD symptoms ICD adverse effect codes: E935.0, E935.1, E935.2, and Y45.0 Symptom codes: 276.4, 292.1, , 292.8, 486, 496, , , , 780.0, , , , , , 799.0, 970.1, E950-E959. E962.0, and J , KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 5

6 Design and Methods: Chart Audits & Interviews Chart audits to validate coded medical terminology Chart audits also determined: Drugs and medications involved, including alcohol Whether events were intentional (i.e., suicide attempts) Evidence of misuse and abuse Interviews to gain addition insight into OOP events 71 OOP event survivors 19 family members following fatal OOP events 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 6

7 Opioid Adverse Effect Codes vs. Chart Review 127 events Chart review 13% (n = 17) were OOP events Adverse effect codes plus overdose symptom codes had a low positive predictive value (13%) 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 7

8 Opioid Poisoning Codes vs. Chart Review 2100 events Chart review 1487 OOP events not related to inpatient anesthesia 71% (1487/2100) positive predictive value to detect OOP events not related to inpatient anesthesia Poisoning codes appear promising 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 8

9 ICD Poisoning Codes vs. Chart Review 2100 identified events events had information in chart, claims, or death data files 10 events (0.5%) had no information available from any data source 1849 events (88.0%) were not related to anesthesia 241 events were related to anesthesia or surgical procedures and were excluded 1 Includes 385 events based on claims or death data 2 Miscode: event documentation does not match with EMR codes used to identify event, meaning that the code does not match what happened at the time of the event 3 Unintentional events include both medical errors and misuse/abuse events 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 1776 events (84.6%) were single or poly-drug poisoning events and were correctly coded 73 events were miscoded 2 or a determination could not be made 1091 events (52.0%) were unintentional OOP events events (18.8%) were OOP events with an indication the event was a suicide attempt 285 events (13.6%) were opioid-related adverse events (not OOP events) 4 were events where a determination could not be made 9

10 Opioid Poisoning Codes Categorized Based on Medical Chart Review % of Opioid Poisoning codes that are Overdoses 60% 50% 40% 30% 20% 10% 0% 0.5% 3.5% 11.5% 13.6% 18.9% 52.1% 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 10

11 Potential Algorithms to Improve Positive Predictive Value Develop diagnostic algorithms that exclude events identified in the medical record and related to analgesia/surgery (n = 241) 80% PPV (1487/1859) exclude opioid adverse events (n = 285) and overdose related to anesthesia/surgery (n = 241) 94% PPV (1487/1574) 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 11

12 ICD Poisoning Codes vs. Chart Review Focus on Unintentional Events 2100 identified events events had information in chart, claims, or death data files 10 events (0.5%) had no information available from any data source 1849 events (88.0%) were not related to anesthesia 241 events were related to anesthesia or surgical procedures and were excluded 1 Includes 385 events based on claims or death data 2 Miscode: event documentation does not match with EMR codes used to identify event, meaning that the code does not match what happened at the time of the event 3 Unintentional events include both medical errors and misuse/abuse events 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 1776 events (84.6%) were single or poly-drug poisoning events and were correctly coded 73 events were miscoded 2 or a determination could not be made 1091 events (52.0%) were unintentional OOP events events (18.8%) were OOP events with an indication the event was a suicide attempt 285 events (13.6%) were opioid-related adverse events (not OOP events) 4 were events where a determination could not be made 12

13 Unintentional OOP Events With Chart Audit Data Abuse/Misuse 87% Illicit Drugs 79% Prescription Drug Abuse 60% Illicit Drug and Prescription Drug Abuse 52% 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 13

14 Interviews with OOP Survivors (n = 69) and Family Members of OOP Decedants (n = 18) Characteristics Number (N of cases=87) 1 Single opioid event 15 Polysubstance event 72 Active benzodiazepine prescription 32 Benzodiazepine present at OOP event 28 Cases involving heroin 17 Total active prescription opioids at time of event, mean (SD) 1.3 Total opioids involved in event including heroin, mean (SD) 1.5 Total prescription medications involved in event, including prescription opioids, mean (SD) 2.2 Total prescription and non-prescription drugs involved or present 2 in the event, mean (SD) We oversampled individuals who had no prescription opioid; 42% (n = 38) of interviews targeted events in this group. Data were derived from EMRs, chart audits, and interviews. 3 interviews were excluded after review because events could not be classified as OOP events (N = 90 prior to exclusions) 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 14

15 Interviews with Survivors and Family Members: Sources of Opioids 1 Number (N of events=87) Multiple sources for opoids involved in OOP event 4 Own active Rx(s) 47 Own expired Rx 7 Family member 8 Friend 8 Street 15 Stolen (not family or friend) 1 Unclear 5 1 Data derived from chart audits and interviews. Only opioids, not other medications or drugs involved in the event, are included. The remaining six events were determined from the interview data. Seven patients reported using their own expired prescription opioids, something that was not captured in the chart abstraction. 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 15

16 Qualitative Analysis Theme #1: Participants Lives Were Often in Disorder Family histories of AOD problems or drug initiation Personal addiction and/or mental health problems Stressful situations (e.g., familial or financial difficulties) Multiple chronic illnesses, chronic pain, and functional deficits Multiple prescriptions for medications, Increased risk of cognitive difficulties, other physical risks, or interactions with opioids Saving old prescriptions Using when not prescribed Using for suicide Easily stolen by family/friends/caregivers 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 16

17 Qualitative Analysis Theme #2: Involvement in Drug Subcultures and Crime Criminal or related activities Theft of medications Diversion of medications Purchase of drugs/medications from friends or on the street Altering route of administration for prescription medications Sharing drugs Taking other drugs/medications to enhance effects of opioids Using heroin 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 17

18 Implications for Policy & Practice Validation of ICD opioid overdose and poisoning codes facilitates and standardizes research methods Currently 71% positive predictive value Develop diagnostic algorithms to improve positive predictive value of coded medical terminology to 80% or 94% OOP events identified through EMRs can Monitor and track trends in OOP events Evaluate effects of regulatory changes Assess effects of new technologies (e.g., tamper-resistant opioid formulations) Interviews enrich description and understanding of OOP events 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 18

19 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 19

20 OOP Poisoning ICD Codes ICD 9 Code Poisoning by opium (alkaloids) unspecified Poisoning by heroin Poisoning by methadone Poisoning by other opiates and related narcotics Accidental poisoning by heroin E850.0 Accidental poisoning by methadone E850.1 Accidental poisoning by other opiates and related narcotics E850.2 COD: Poisoning by opiates and related narcotics (for the year of 1998 only; COD codes changed to ICD 10 in 1999; ICD 9 codes used for death data during 1998 did not include the fifth digit, which is why this particular 9650 code is four digits and without a decimal) ICD 10 Code COD: Poisoning by opium T40.0 COD: Poisoning by heroin T40.1 COD: Poisoning by other opioids T40.2 COD: Poisoning by methadone T40.3 COD: Poisoning by other synthetic narcotic T40.4 COD: Accidental poisoning by and exposure to narcotics and psychodysleptics, not elsewhere classified X42 COD: Intentional self-poisoning by and exposure to narcotics and psychodysleptics, not elsewhere classified X62 COD: Undetermined poisoning by and exposure to narcotics and psychodysleptics, not elsewhere classified Y , KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 20

21 Adverse Event* ICD Codes Code Category Diagnosis ICD 9 Code ICD 10 Code HCPCS Code 2a Adverse effects of heroin E a Adverse effects of methadone E a Adverse effects of other opioids and related narcotics E a COD: Adverse effects of opioids and related analgesics Y45.0 2b Mixed acid base balance disorder b Drug-induced psychotic disorders (including and ) b Drug-induced delirium b Drug-induced mental disorder (excluding ) 292.8** 2b Pneumonia, organism unspecified 486 2b Chronic airway obstruction, not elsewhere classified 496 2b Acute respiratory failure b Other pulmonary insufficiency, not elsewhere classified b Rhabdomyolysis b Alteration of consciousness 780.0** 2b Altered mental state b Apnea b Shortness of breath b Dyspnea and respiratory abnormalities other b Painful respiration b Asphyxia and hypoxemia 799.0** 2b Poisoning by opiate antagonists b Suicide and self-inflicted injury E950 E959 2b Assault by drugs and medicinal substances E b Injection, Naloxone Hydrochloride J2310 *Adverse event definition is met when a code from 2a and one or more 2b codes occur on the same date **includes all sub-codes except where noted 2014, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH 21

Appendix 14: Obtaining Data on Opioid Poisoning

Appendix 14: Obtaining Data on Opioid Poisoning : Obtaining Data on Opioid Poisoning Obtaining Hospital Data on Nonfatal Opioid Poisoning Data on the number of nonfatal opioid overdoses can often be obtained from hospitals serving your community. Forming

More information

FINAL REPORT JULY 2015. Opioid Prescribing and Opioid-Related Hospital Visits in Ontario

FINAL REPORT JULY 2015. Opioid Prescribing and Opioid-Related Hospital Visits in Ontario FINAL REPORT JULY 2015 Opioid Prescribing and Opioid-Related Hospital Visits in Ontario 2 The (ODPRN) is funded to conduct pharmacoepidemiology and drug policy research as part of an initiative to provide

More information

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9 Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...

More information

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013 Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization

More information

How To Improve Care For A Chronic Pain Patient

How To Improve Care For A Chronic Pain Patient Using Integrated Health Plan EMR Data to Evaluate Outcomes Associated with Clinical Services for the Treatment of Non-Malignant Chronic Pain Lynn L DeBar, PhD MPH Center for Health Agenda Utilizing EMR

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

CCW Task Order 16: Round 3 Clinical Condition Algorithms. Page 1 of 5 ICD-9 CODE DESCRIPTION ICD-9 CODE

CCW Task Order 16: Round 3 Clinical Condition Algorithms. Page 1 of 5 ICD-9 CODE DESCRIPTION ICD-9 CODE DESCRIPTION 292 Drug-induced mental disorders 2920 Drug withdrawal 29211 Drug-induced psychotic disorder with delusions 29212 Drug-induced psychotic disorder with hallucinations 2922 Pathological drug

More information

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,

More information

Prescription Opioid Overdose & Misuse in Oregon

Prescription Opioid Overdose & Misuse in Oregon Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing

More information

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution

More information

Drug Associated Deaths

Drug Associated Deaths Drug Associated Deaths Dr. Caryl Beynon Reader in Substance Use Epidemiology Centre for Public Health, Liverpool John Moores University Email: c.m.beynon@ljmu.ac.uk Web: www.cph.org.uk Overview 1. Define

More information

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational

More information

Drug-related deaths in Scotland in 2013

Drug-related deaths in Scotland in 2013 Drug-related deaths in Scotland in 2013 Statistics of drug-related deaths in 2013 and earlier years, broken down by age, sex, selected drugs reported, underlying cause of death and NHS Board and Council

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

CHARGES FOR DRUG-RELATED INPATIENT HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS IN KENTUCKY, 2009-2013

CHARGES FOR DRUG-RELATED INPATIENT HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS IN KENTUCKY, 2009-2013 CHARGES FOR DRUG-RELATED INPATIENT HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS IN KENTUCKY, 2009-2013 Prepared for the Kentucky Injury Prevention & Research Center by: Huong Luu, MD, MPH W. Jay Christian,

More information

Substance Abuse 2014-2015. Chapter 10: Substance Abuse

Substance Abuse 2014-2015. Chapter 10: Substance Abuse Substance Abuse 214-215 Chapter 1: Substance Abuse 265 214-215 Health of Boston Substance Abuse Substance abuse involves the excessive use of alcohol or illicit substances (e.g., marijuana, cocaine, heroin,

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP

More information

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer

More information

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii. THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature

More information

Overdose Prevention and Management in Opioid Treatment Programs

Overdose Prevention and Management in Opioid Treatment Programs Overdose Prevention and Management in Opioid Treatment Programs AATOD 2010 1:30pm Tuesday, October 26, 2010 Moderator: Amina Chaudhry Faculty: Melinda Campopiano Maya Doe-Simkins Alexander Y. Walley Disclosures

More information

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING [R23-1-OPOIDR] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH April 2014 (E) COMPILER S NOTES: Proposed Additions: The

More information

PRESCRIPTION PAINKILLER OVERDOSES

PRESCRIPTION PAINKILLER OVERDOSES IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky

More information

Opportunities to Test Effective Opiate Treatments

Opportunities to Test Effective Opiate Treatments National Drug Abuse Treatment Clinical Trials Network Forging partnerships to improve the quality of drug abuse treatment throughout the nation. Opportunities to Test Effective Opiate Treatments Walter

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

Module 6 Alcoholism, Drug Abuse and Corruption

Module 6 Alcoholism, Drug Abuse and Corruption Module 6 Alcoholism, Drug Abuse and Corruption Lecture 36 Drug Abuse: Concept, Extent and Nature Concept Any substance (usually chemical) which influences our bodies or emotions when consumed may be called

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

Arkansas Emergency Department Opioid Prescribing Guidelines

Arkansas Emergency Department Opioid Prescribing Guidelines Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular

More information

Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director

Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Illicit Drugs Marijuana Prescription Drug Misuse/Abuse is a Major Problem in the US Current

More information

PTSD, Opioid Dependence, and EMDR: Treatment Considerations for Chronic Pain Patients

PTSD, Opioid Dependence, and EMDR: Treatment Considerations for Chronic Pain Patients PTSD, Opioid Dependence, and EMDR: Treatment Considerations for Chronic Pain Patients W. Allen Hume, Ph.D.,C.D.P. Licensed Psychologist www.drallenhume.com October 2, 2007 COD client with PTSD seeking

More information

9. Substance Abuse. pg 166-169: Self-reported alcohol consumption. pg 170-171: Childhood experience of living with someone who used drugs

9. Substance Abuse. pg 166-169: Self-reported alcohol consumption. pg 170-171: Childhood experience of living with someone who used drugs 9. pg 166-169: Self-reported alcohol consumption pg 170-171: Childhood experience of living with someone who used drugs pg 172-173: Hospitalizations related to alcohol and substance abuse pg 174-179: Accidental

More information

Opioid/Opiate Dependent Pregnant Women

Opioid/Opiate Dependent Pregnant Women Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than

More information

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100

More information

Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu

Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy

More information

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name.

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. Welcome! 1 This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. 2 Definitive treatment for an opioid or opiate overdose

More information

Drug Overdose Deaths, Hospitalizations, Abuse & Dependency among Oregonians

Drug Overdose Deaths, Hospitalizations, Abuse & Dependency among Oregonians 214 Drug Overdose Deaths, Hospitalizations, Abuse & Dependency among Oregonians Oregon Health Authority Center for Prevention & Health Promotion, Injury & Violence Prevention Section 5/3/214 Drug Overdose

More information

Drug- and Alcohol-Related Intoxication Deaths in Maryland, 2014

Drug- and Alcohol-Related Intoxication Deaths in Maryland, 2014 Maryland Department of Health and Mental Hygiene Larry Hogan, Governor Boyd Rutherford, Lt. Governor Van Mitchell, Secretary May, 215 Drug- and Alcohol-Related Intoxication Deaths in Maryland, 214 Table

More information

Drug Testing to Support Pain Management

Drug Testing to Support Pain Management NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of

More information

The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis

The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians

More information

National Perspectives in Medication Assisted Treatment

National Perspectives in Medication Assisted Treatment National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit

More information

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013 Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions

More information

A Review of the Impacts of Opiate Use in Ontario: Summary Report

A Review of the Impacts of Opiate Use in Ontario: Summary Report A Review of the Impacts of Opiate Use in Ontario: Summary Report A Provincial Summary Report of the Impacts of the Discontinuation of Oxycontin in Ontario: January to August 2013 December 2013 This report

More information

Issue Brief Prescription Drug Misuse in Vermont

Issue Brief Prescription Drug Misuse in Vermont Issue Brief Prescription Drug Misuse in Vermont STATE EPIDEMIOLOGICAL OUTCOMES WORKGROUP - JUNE, 214 Summary Discrepancies between the perceived problem of prescription drug misuse in Vermont and several

More information

John R. Kasich, Governor Orman Hall, Director

John R. Kasich, Governor Orman Hall, Director John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic

More information

Local Coverage Determination (LCD) for Qualitative Drug Screening (L30574)

Local Coverage Determination (LCD) for Qualitative Drug Screening (L30574) Local Coverage Determination (LCD) for Qualitative Drug Screening (L30574) Contractor Information Contractor Name First Coast Service Options, Inc. Back to Top Contractor Number 09102 Contractor Type MAC

More information

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use

More information

Allyse Adams PC, LICDC Oriana House, Inc.

Allyse Adams PC, LICDC Oriana House, Inc. Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,

More information

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents

More information

Supplementary Table 1. Cohort (shaded) who have at least one emergency. admission for injury between 10 and 19 years old in 1998-2011 (N = 402,916)

Supplementary Table 1. Cohort (shaded) who have at least one emergency. admission for injury between 10 and 19 years old in 1998-2011 (N = 402,916) Supplementary Tables Supplementary Table 1. Cohort (shaded) who have at least one emergency admission for injury between 10 and 19 years old in 1998-2011 (N = 402,916) 1998 1999 2000 2001 2002 2007 2008

More information

Populations at risk for opioid overdose

Populations at risk for opioid overdose Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April

More information

WA Opioid Dosing Guidelines Centers for Disease Control 1/14/2009

WA Opioid Dosing Guidelines Centers for Disease Control 1/14/2009 WA Opioid Dosing Guidelines Centers for Disease Control 1/14/2009 Gary M. Franklin, MD, MPH Research Professor Departments of Environmental Health and Neurology University of Washington Medical Director

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century Mother s little helper: Prescription drug abuse in the 21 st century Carol Falkowski CEO and Founder Drug Abuse Dialogues St. Paul, Minnesota www.drugabusedialogues.com More kids smoke marijuana than smoke

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Introduction to Neonatal Abstinence Syndrome

Introduction to Neonatal Abstinence Syndrome Introduction to Neonatal Abstinence Syndrome Cara Christ, MD Director, Arizona Department of Health Services Learning Objectives 1.Define Neonatal Abstinence Syndrome 2.Describe Neonatal Abstinence Syndrome

More information

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015 Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in

More information

3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle

3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle Substance Abuse and Misuse: A Tragic Market That Can Be Curtailed Tennessee Department of Health Protect, promote, and improve the health and prosperity of persons in the State of Tennessee. John J. Dreyzehner,

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

Pekka Heinälä Multiple substance use a challenge for treatment and prevention

Pekka Heinälä Multiple substance use a challenge for treatment and prevention Pekka Heinälä Multiple substance use a challenge for treatment and prevention Finn-Czech Media Seminar on Substances Addicted Society today and in the future Prague 9 through 12 September 2010 Multiple

More information

SENATE BILL 871. By Dickerson BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:

SENATE BILL 871. By Dickerson BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE: SENATE BILL 871 By Dickerson AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 56 and Title 63, relative to substance abuse. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:

More information

Prescription Drug Abuse and Overdose: Public Health Perspective

Prescription Drug Abuse and Overdose: Public Health Perspective Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October

More information

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin

More information

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate

More information

Substance Abuse Issues in Pain Management

Substance Abuse Issues in Pain Management Substance Abuse Issues in Pain Management Steven D. Passik, PhD Associate Attending Psychologist Memorial Sloan Kettering Cancer Center New York, NY Opioid Rhetoric: From Complete Avoidance to Complete

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us

More information

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL Purpose: To reduce morbidity and mortality from opioid overdose. Policy: Under

More information

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City

More information

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real

More information

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department

More information

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This

More information

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose What is an opioid? Opioids are a type of pain-relief medication. According to the National Institute on Drug

More information

Heroin Addiction. Kim A. Drury RN, MSN

Heroin Addiction. Kim A. Drury RN, MSN Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services

More information

6/19/2014. Opiate and Heroin Abuse in Rural Communities Litchfield County Opiate Task Force

6/19/2014. Opiate and Heroin Abuse in Rural Communities Litchfield County Opiate Task Force Opiate and Heroin Abuse in Rural Communities Litchfield County Opiate Task Force Joy Pendola; LMFT, LADC, Clinical Manager of DDIOP and Adult Behavioral Health Services at the Charlotte Hungerford Hospital

More information

Presentation by: Commissioner E. Douglas Varney

Presentation by: Commissioner E. Douglas Varney Presentation by: Commissioner E. Douglas Varney Prescription Drug Abuse Affects Everyone Families as a whole Women Children The abuse of prescription drugs, particularly opioids, is costly not only for

More information

We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones

We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones Learn about the history of opioid addiction and discuss what is happening today in Kentucky Learn about the disease of

More information

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,

More information

Addiction Psychiatry Fellowship Rotation Goals & Objectives

Addiction Psychiatry Fellowship Rotation Goals & Objectives Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction

More information

Macomb County Office of Substance Abuse MCOSA. Executive Summary

Macomb County Office of Substance Abuse MCOSA. Executive Summary Macomb County Office of Substance Abuse MCOSA Executive Summary This report marks the second data profile of alcohol and illicit drugs burden in Macomb County. The first report produced in 2007 detailed

More information

Opiate Trends. Multnomah County, 2004-2014. December 2015

Opiate Trends. Multnomah County, 2004-2014. December 2015 Opiate Trends Multnomah County, 2004-2014 December 2015 CREATED: 11.24.2015 Table of Contents Executive Summary... 3 Opiate Overdose Deaths... 4 Ambulance Response to overdose... 10 Syringe Exchange and

More information

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014 Outcomes for Opiate Users at FRN Facilities FRN Research Report September 2014 Introduction The illicit use of opioids has reached epidemic proportions in the United States (Alford, 2007; Meges et al,

More information

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment

Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics

More information

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data Volume #1 October 2015 PUBLIC HEALTH ISSUE BRIEF Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data October 2015 Partners for a Healthier Community, Inc.

More information

The Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT

The Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT The Opiate Epidemic Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT Connections Counseling Madison, WI www.connectionscounseling.com The Opiate Epidemic Opioid-related Facts

More information

MEDICAL POLICY Treatment of Opioid Dependence

MEDICAL POLICY Treatment of Opioid Dependence POLICY........ PG-0313 EFFECTIVE......11/11/14 LAST REVIEW... 07/14/15 MEDICAL POLICY Treatment of Opioid Dependence GUIDELINES This policy does not certify benefits or authorization of benefits, which

More information

Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers

Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer

More information

PREAMBLE Whereas, Whereas, Whereas Whereas Whereas Whereas

PREAMBLE Whereas, Whereas, Whereas Whereas Whereas Whereas PREAMBLE Whereas, Josephine County, an economically depressed county in the State of Oregon, under severe financial duress, with a depleted Criminal Justice System, has a growing population with epidemic

More information

Southlake Psychiatry. Suboxone Contract

Southlake Psychiatry. Suboxone Contract Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to

More information

How To Treat Anorexic Addiction With Medication Assisted Treatment

How To Treat Anorexic Addiction With Medication Assisted Treatment Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious

More information

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Beyond SBIRT: Integrating Addiction Medicine into Primary Care Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison

More information

Use of Pharmacotherapies by Substance Abuse Treatment Facilities

Use of Pharmacotherapies by Substance Abuse Treatment Facilities Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1

More information

Ohio Department of Health APRIL 17, 2014

Ohio Department of Health APRIL 17, 2014 Ohio Department of Health OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: APRIL 17, 2014 EPIDEMIOLOGY, CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS PRESENTATION OVERVIEW Epidemiology of drug overdose

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for

More information

Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data

Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data William C. Becker, MD Assistant Professor, General Internal Medicine VA Connecticut

More information

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons. Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize

More information